Switch to:
GuruFocus has detected 5 Warning Signs with Teva Pharmaceutical Industries Ltd $TEVA.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
Teva Pharmaceutical Industries Ltd (NYSE:TEVA)
Capital Expenditure
$-901 Mil (TTM As of Dec. 2016)

Cash flow for capital expenditures refers to the cash generated minus spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Teva Pharmaceutical Industries Ltd's cash flow for capital expenditures for the three months ended in Dec. 2016 was $-333 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Dec. 2016 was $-901 Mil.


Definition

Cash flow for capital expenditures refers to the cash generated minus spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Teva Pharmaceutical Industries Ltd Capital Expenditure for the trailing twelve months (TTM) ended in Dec. 2016 was -172 (Mar. 2016 ) + -175 (Jun. 2016 ) + -221 (Sep. 2016 ) + -333 (Dec. 2016 ) = $-901 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Teva Pharmaceutical Industries Ltd Annual Data

Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15Dec16
Cash Flow_CPEX -542-681-719-710-1,053-1,104-1,031-929-772-901

Teva Pharmaceutical Industries Ltd Quarterly Data

Sep14Dec14Mar15Jun15Sep15Dec15Mar16Jun16Sep16Dec16
Cash Flow_CPEX -212-300-185-169-170-248-172-175-221-333
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK